FDA Panel To Consider Strategies For Timely Completion Of Accelerated Approval Confirmatory Trials

 
• By Sue Sutter
  
Hammer
FDA may be more willing to bring down the hammer on oncology accelerated approval drug sponsors who fail to conduct their confirmatory trials with due diligence. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers